Skip to main content
SpringerLink
Log in

Response to: Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature

  • REPLY
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Greenlees R, Neville A, Addor MC, Amar E, Arriola L, Bakker M, Barisic I, Boyd PA, Calzolari E, Doray B, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A. 2011;91(S1):S51–100.

    Article  CAS  Google Scholar 

  2. Garne E, Dolk H, Lonae M, Boyd P, EUROCAT Working Group. EUROCAT website data on prenatal detection rates of congenital anomalies. J Med Screen. 2010;17(2):97–8.

    Article  PubMed  Google Scholar 

  3. EUROCAT. EUROCAT: Guide 1.3 and reference documents. 2013. http://www.eurocat-network.eu/content/EUROCAT-Guide-1.3.pdf. Accessed 11 Sept 2015.

  4. Palmsten K, Huybrechts KF, Kowal MK, Mogun H, Hernández-Díaz S. Validity of maternal and infant outcomes within nationwide medicaid data. Pharmacoepidemiol Drug Saf. 2014;23(6):646–55.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Hook EB, Swan SH, Shaw GM, Schulman J. Normal or affected controls in case–control studies of congenital malformations and other birth defects: reporting bias issues. Epidemiology. 1993;182–4.

  6. Lieff S, Olshan AF, Werler M, Savitz DA, Mitchell AA. Selection bias and the use of controls with malformations in case–control studies of birth defects. Epidemiology. 1999;10(3):238–41.

    Article  PubMed  CAS  Google Scholar 

  7. Schlesselman JJ. Case control studies: design, conduct, analysis. Oxford: Oxford University Press; 1982.

    Google Scholar 

  8. EUROCAT. EUROCAT Special report: sources of information of medication use in pregnancy. EUROCAT Central Registry, University of Ulster. 2014. http://www.eurocat-network.eu/AboutUs/Publications/Publications/Medication%20During%20Pregnancy. Accessed 11 Sept 2015.

  9. Prieto L, Martinez-Frias ML. Case–control studies using only malformed infants: are we interpreting the results correctly? Teratology. 1999;60:1–2.

    Article  PubMed  CAS  Google Scholar 

  10. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, de Jong-van den Berg LT. Valproic acid monotherapy in pregnancy and major congenital malformations. New Engl J Med. 2010;362(23):2185–93.

    Article  PubMed  CAS  Google Scholar 

  11. Charlton RA, Jordan S, Pierini A, Garne E, Neville AJ, Hansen AV, Gini R, Thayer D, Tingay K, Puccini A, Bos HJ, Nybo Andersen AM, Sinclair M, Dolk H, de Jong-van den Berg LTW. Selective serotonin reuptake inhibitor prescribing before, during and after pregnancy: a population-based study in six European regions. BJOG: Int J Obstet Gynaecol. 2014;122:1010–20.

    Article  Google Scholar 

  12. De Jonge L, Garne E, Gini R, Jordan SE, Klungsoyr K, Loane M, Neville AJ, Pierini A, Puccini A, Thayer DS. Improving information on maternal medication use by linking prescription data to congenital anomaly registers: a EUROmediCAT study. Drug Saf. 2015;38(11):1083-93.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Reefhuis J, Divine O, Friedman JM, Louik C, Honein MA. Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports. 2015;h3190. doi:10.1136/bmj.h3190.

  14. Jimenez-Solem E, Andersen JT, Petersen M, Broedbaek K, Jensen JK, Afzal S, Gislason GH, Torp-Pedersen C, Poulsen HE. Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study. BMJ Open. 2012;2(3):e001148.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Colvin L, Slack-Smith L, Stanley FJ, Bower C. Dispensing patterns and pregnancy outcomes for women dispensed selective serotonin reuptake inhibitors in pregnancy. Birth Defects Res Part A Clin Mol Teratol. 2011;91(3):142–52.

    Article  PubMed  CAS  Google Scholar 

  16. Kornum JB, Nielsen RB, Pedersen L, Mortensen PB, Nørgaard M. Use of selective serotonin-reuptake inhibitors during early pregnancy and risk of congenital malformations: updated analysis. Clin Epidemiol. 2010;2:29–36.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Wurst KE, Poole C, Ephross SA, Olshan AF. First trimester paroxetine use and the prevalence of congenital, specifically cardiac, defects: a meta-analysis of epidemiological studies. Birth Defects Res A Clin Mol Teratol. 2010;88:159–70.

    Article  PubMed  CAS  Google Scholar 

  18. Nordeng H, van Gelder MM, Spigset O, Koren G, Einarson A, Eberhard-Gran M. Pregnancy outcome after exposure to antidepressants and the role of maternal depression: results from the Norwegian mother and child cohort study. J Clin Psychopharm. 2012;32:186–94.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre for Maternal, Fetal and Infant Research, Institute of Nursing and Health Research, University of Ulster, Jordanstown Campus, Shore Road, Newtownabbey, Co. Antrim, BT37 0QB, UK

    Helen Dolk

  2. School of Allied Health Sciences, University for Development Studies, P O Box TL 1883, Tamale, N/R, Ghana

    Anthony Wemakor

Authors
  1. Helen Dolk
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anthony Wemakor
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Helen Dolk.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dolk, H., Wemakor, A. Response to: Case–control studies require appropriate population controls: an example of error in the SSRI birth defect literature. Eur J Epidemiol 30, 1219–1221 (2015). https://doi.org/10.1007/s10654-015-0099-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-015-0099-1

Keywords

Search

Navigation